Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
Advances in anti-epileptic drug testing
Matthew D Krasowski1, Gwendolyn A McMillin2
1Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, United States.
Therapeutic drug monitoring aids in managing epilepsy with 17 new antiepileptic drugs. Key drugs like lamotrigine and levetiracetam benefit most from monitoring, with alternative specimens like saliva also discussed.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Neurology
Background:
- Over the last 21 years, 17 new antiepileptic drugs (AEDs) have been approved in the US and/or Europe.
- These newer AEDs represent significant advancements in epilepsy treatment.
- Therapeutic drug monitoring (TDM) is a crucial tool in optimizing drug therapy.
Purpose of the Study:
- To review the role and necessity of TDM for recently approved AEDs.
- To identify which of the newer AEDs have the strongest justification for TDM.
- To discuss alternative biological matrices for TDM.
Main Methods:
- Review of recently approved AEDs and their pharmacokinetic properties.
- Identification of AEDs with narrow therapeutic indices or significant inter-individual variability.
- Evaluation of existing literature on TDM for newer AEDs.
- Consideration of alternative specimen types such as saliva and dried blood spots.
Main Results:
- Lamotrigine, levetiracetam, oxcarbazepine, stiripentol, and zonisamide are identified as having the best justifications for TDM.
- Perampanel, stiripentol, and tiagabine exhibit high protein binding, suggesting monitoring of free drug fractions may be beneficial.
- Saliva and dried blood spots are presented as viable alternative specimens for TDM.
Conclusions:
- TDM is essential for effective clinical dosing of many newer AEDs.
- Specific AEDs warrant focused TDM strategies based on their properties.
- Exploring alternative specimens can enhance TDM accessibility and patient convenience in epilepsy management.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists

